Fundraising Fox
Jonathan Milner
InvestorInvestor at Cambridge Innovation Capital
Cambridge, Massachusetts
Writes $5K – $50K checks · typically $25K
Find your path to Jonathan
Sign up to see every warm intro you have to Jonathan
- Paths you didn't know you had: your email and LinkedIn already hold routes to Jonathan. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Jonathan Milner earned a doctorate in Molecular Genetics at Leicester University after studying Applied Biology at Bath University, where he later worked as a post-doctoral researcher from 1992 to 1995. He subsequently researched the molecular basis of breast cancer at the University of Cambridge in Professor Tony Kouzarides' laboratory, and in 1998 co-founded the antibody supplier Abcam with David Cleevely and Professor Kouzarides. He has supported over 60 companies and helped bring three technology companies to IPO on AIM.
Invests in
Biotech
Investments
Board seats
Axol BioscienceCamallergy LimitedElpis Biomedical LimitedHealX LimitedPhoreMost LimitedRepositive LimitedShift Biosciencs LimitedSyndicate Room Limited
Investor
52 NorthAxol BioscienceBactobiobit.bioCaliraClock BioConstructive BioDesktop GeneticsEagle GenomicsEpitopeaExciting InstrumentsGelmetixGeneAdviserGeoSpockHealxHorizon DiscoveryImophoronInviziusLIfT BioSciencesMogrifyNanoSyrinxNatroxNucleraPangaea DataPencil BiosciencesPharmEnablePhoreMostpixlbio (formerly DefiniGEN)QkineQuibimRelation TherapeuticsSense BiodetectionShift BioscienceSolasCureSpireaSyndicateRoomTotientValence Discovery
Sources: the firm's website · curated public sources.
Colleagues at Cambridge Innovation Capital
Network3
)
Investors connected to Jonathan in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Jonathan Milner?
- Jonathan Milner earned a doctorate in Molecular Genetics at Leicester University after studying Applied Biology at Bath University, where he later worked as a post-doctoral researcher from 1992 to 1995. He subsequently researched the molecular basis of breast cancer at the University of Cambridge in Professor Tony Kouzarides' laboratory, and in 1998 co-founded the antibody supplier Abcam with David Cleevely and Professor Kouzarides. He has supported over 60 companies and helped bring three technology companies to IPO on AIM.
- Where does Jonathan Milner work?
- Jonathan Milner is at Cambridge Innovation Capital.
- What does Jonathan Milner invest in?
- Jonathan Milner invests in Biotech.
- What check size does Jonathan Milner write?
- Jonathan Milner typically writes checks of $5K – $50K.
- What boards does Jonathan Milner sit on?
- Jonathan Milner holds tracked board seats at Axol Bioscience, Camallergy Limited, Elpis Biomedical Limited, HealX Limited, PhoreMost Limited, Repositive Limited, Shift Biosciencs Limited, Syndicate Room Limited.
- What companies has Jonathan Milner invested in?
- Investments tracked here include 52 North, Axol Bioscience, Bactobio, bit.bio, Calira, Clock Bio, Constructive Bio, Desktop Genetics, Eagle Genomics, Epitopea, Exciting Instruments, Gelmetix, and 26 more.
Founder mafias
University of Bath mafia82
Also came through, then founded or led a company.
University of Leicester mafia25
Also came through, then founded or led a company.
Anglia Ruskin University mafia13
Also came through, then founded or led a company.
Cambridge Innovation Capital mafia5
Also came through, then founded or led a company.
Definigen mafia4
Also came through, then founded or led a company.
About this profile. Compiled from public sources — Cambridge Innovation Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights